Nonalcoholic steatohepatitis (NASH) with diabetes: predictors of liver fibrosis
Introduction: Nonalcoholic steatohepatitis (NASH) is common cause of chronic liver disease strongly associated with insulin resistance leading to fibrosis. No factors that determine increasing fibrosis have been well recognized. Liver biopsy is considered as gold standard for diagnosis and prognosis...
Main Authors: | D.N. Amarapurkar, A.D. Amarapurkar, N.D. Patel, S. Agal, R. Baigal, P. Gupte, S. Pramanik |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2006-01-01
|
Series: | Annals of Hepatology |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1665268119320368 |
Similar Items
-
Effects of green tea catechins on nonalcoholic steatohepatitis (NASH) patients
by: Yoshitaka Fukuzawa, et al.
Published: (2014-07-01) -
Current Status in Testing for Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH)
by: Hannah K. Drescher, et al.
Published: (2019-08-01) -
Overexpression of the Vitronectin V10 Subunit in Patients with Nonalcoholic Steatohepatitis: Implications for Noninvasive Diagnosis of NASH
by: Maria Del Ben, et al.
Published: (2018-02-01) -
Recent update: Nonalcoholic steatohepatitis
by: Vivek Hande, et al.
Published: (2018-01-01) -
World Gastroenterology Organisation global guidelines:nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
by: ZHU Peng
Published: (2014-09-01)